Related references
Note: Only part of the references are listed.Comparison of the Antibacterial Properties of Phage Endolysins SAL-1 and LysK
Soo Youn Jun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance
Gregory Resch et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Immunostimulation with Macrophage-Activating Lipopeptide-2 Increased Survival in Murine Pneumonia
Katrin Reppe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Phosphodiesterase 2 inhibition diminished acute lung injury in murine pneumococcal pneumonia
Martin Witzenrath et al.
CRITICAL CARE MEDICINE (2009)
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia
Martin Witzenrath et al.
CRITICAL CARE MEDICINE (2009)
Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance
D. E. Ghannam et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Katherine L. O'Brien et al.
LANCET (2009)
Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis
Denis Grandgirard et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: A systematic review and meta-analysis
IM Tleyjeh et al.
CLINICAL INFECTIOUS DISEASES (2006)
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats
JM Entenza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bacteriophage endolysins - current state of research and applications
MJ Loessner
CURRENT OPINION IN MICROBIOLOGY (2005)
Synergistic killing of streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance
S Djurkovic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
A Michalopoulos et al.
CRITICAL CARE (2005)
Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage, lytic enzyme
Q Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients
JR Badia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor
B Schmeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The antineutrophil cytoplasmic antibody-associated vasculitides
P Seo et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model
I Jado et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The Alexander Project 1998-2000:: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents
MR Jacobs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test:: a prospective, controlled clinical evaluation
MD Smith et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains
JM Loeffler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia
JM Loeffler et al.
INFECTION AND IMMUNITY (2003)
The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones
R Pallares et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
A bacteriolytic agent that detects and kills Bacillus anthracis
R Schuch et al.
NATURE (2002)
Estimates of world-wide distribution of child deaths from acute respiratory infections
BG Williams et al.
LANCET INFECTIOUS DISEASES (2002)
Modulation of release of proinflammatory bacterial compounds by antibacterials: Potential impact on course of inflammation and outcome in sepsis and meningitis
R Nau et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase
JM Loeffler et al.
SCIENCE (2001)
Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia
DR Murdoch et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis
F Ratjen et al.
LANCET (2001)
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
D Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock
C Joukhadar et al.
CRITICAL CARE MEDICINE (2001)
Share Paper
